Cargando…
Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
Nebivolol is a novel beta(1)-blocker with a greater degree of selectivity for beta(1)-adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating, vasodilatory effect that is unique among beta-blockers currently available to clinicians (nebivolol is approved in Europe a...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993984/ https://www.ncbi.nlm.nih.gov/pubmed/17326335 |